pfizer nyse - Search News

Pfizer (NYSE:PFE) Posts Better-Than-Expected Sales In Q4

Global pharmaceutical company Pfizer (NYSE:PFE) reported Q4 CY2024 results , with sales up 21.9% year on year to $17.76 billion. On the other hand, the company’s full-year revenue guidance of $62.5 billion at the midpoint came in 0.

Investing · 18h

Pfizer stock rises after beating Q4 expectations

Pfizer (NYSE: PFE) posted adjusted earnings per share of $0.63 for Q4, exceeding the analyst consensus of $0.48. Revenue came in at $17.8 billion, above expectations of $17.28 billion.

MarketWatch · 16h

Pfizer Shares Rise on Better-Than-Expected 4Q

The positive quarter caps a busy year of cost cutting and pressure from an activist investor as Pfizer has sought to turn around company performance. Shares rose 1.2% to $26.51 soon after market open.

Zacks.com on MSN · 13h

Pfizer's Q4 Earnings Beat Estimates, Non-Covid Drugs Drive Sales

Pfizer PFE reported fourth-quarter 2024 adjusted earnings per share of 63 cents, which beat the Zacks Consensus Estimate of 48 cents per share. The company had recorded earnings of 10 cents per share in the year-ago quarter.

15h

Pfizer Rises on Q4 Earnings Beat, 2025 Outlook Reaffirmed

Pfizer beats Q4 estimates with 24.9% revenue growth, reaffirming 2025 guidance and targeting $4.5 billion in cost savings ...

10h

Pfizer Q4 Earnings: Solid Results, But Guidance And Patent Concerns Drive The Stock Down

Pfizer's Q4 2024 earnings beat expectations, but concerns over 2025 guidance and patent expirations led to stock decline. See ...

The Armenian Reporter14h

Pfizer Inc. (NYSE:PFE) Shares Sold by PFS Partners LLC

PFS Partners LLC lowered its holdings in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 11.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange ...

15hon MSN

Pfizer beats Q4, FY '24 earnings estimates, stock flat in early trading

Pfizer (PFE) reported fourth quarter and full-year 2024 earnings results Tuesday, narrowly beating Wall Street expectations ...

1don MSN

Pfizer Q4 Earnings Preview: Strong top line growth expected on COVID-19 product demand

Pfizer (PFE) is set to announce Q4 earnings, with analysts expecting a $0.46 profit per share and $17.26B revenue.

The Pharma Letter14h

Pfizer beats sales and earnings forecast in 4th-qtr

US pharma giant Pfizer reported financial results for fourth-quarter and full-year 2024 and reaffirmed its 2025 financial ...

The Armenian Reporter11h

Welch Group LLC Reduces Stock Holdings in Pfizer Inc. (NYSE:PFE)

Welch Group LLC cut its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 35.1% in the fourth quarter, HoldingsChannel reports ...

16h

Pfizer Q4 Results Beat Market; Confirms FY25 Outlook - Update

Drug major Pfizer Inc. (PFE), while reporting a profit in its fourth quarter, compared to prior year's loss, on Tuesday reaffirmed ...

Pfizer (NYSE:PFE) Takes On Some Risk With Its Use Of Debt

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows ...

Pfizer (NYSE:PFE) Price Target Cut to $29.00 by Analysts at Citigroup

Pfizer (NYSE:PFE – Get Free Report) had its price objective decreased by equities research analysts at Citigroup from $30.00 ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results